Pitx2 is an upstream activator of extraocular myogenesis and survival

42Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

The transcription factors required to initiate myogenesis in branchial arch- and somite-derived muscles are known, but the comparable upstream factors required during extraocular muscle development have not been identified. We show Pax7 is dispensable for extraocular muscle formation, whereas Pitx2 is cell-autonomously required to prevent apoptosis of the extraocular muscle primordia. The survival requirement for Pitx2 is stage-dependent and ends following stable activation of genes for the muscle regulatory factors (e.g. Myf5, MyoD), which is reduced in the absence of Pitx2. Further, PITX2 binds and activates transcription of the Myf5 and MyoD promoters, indicating these genes are direct targets. Collectively, these data demonstrate that PITX2 is required at several steps in the development of extraocular muscles, acting first as an anti-apoptotic factor in pre-myogenic mesoderm, and subsequently to activate the myogenic program in these cells. Thus, Pitx2 is the first demonstrated upstream activator of myogenesis in the extraocular muscles. © 2010 Elsevier Inc.

Cite

CITATION STYLE

APA

Zacharias, A. L., Lewandoski, M., Rudnicki, M. A., & Gage, P. J. (2011). Pitx2 is an upstream activator of extraocular myogenesis and survival. Developmental Biology, 349(2), 395–405. https://doi.org/10.1016/j.ydbio.2010.10.028

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free